PT Kalbe Farma Tbk. (KLBF.JK)
IDR 1195.0
(-3.63%)
IDR 1195.0
(-3.63%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3937.54 Billion IDR | -23.45% |
| 2022 | 5143.98 Billion IDR | 16.89% |
| 2021 | 4400.75 Billion IDR | 2.62% |
| 2020 | 4288.21 Billion IDR | 20.48% |
| 2019 | 3559.14 Billion IDR | 24.81% |
| 2018 | 2851.61 Billion IDR | 4.75% |
| 2017 | 2722.2 Billion IDR | -1.45% |
| 2016 | 2762.16 Billion IDR | 0.15% |
| 2015 | 2758.13 Billion IDR | 5.77% |
| 2014 | 2607.55 Billion IDR | -7.37% |
| 2013 | 2815.1 Billion IDR | 37.57% |
| 2012 | 2046.31 Billion IDR | 16.36% |
| 2011 | 1758.61 Billion IDR | 39.51% |
| 2010 | 1260.57 Billion IDR | -25.49% |
| 2009 | 1691.77 Billion IDR | 24.46% |
| 2008 | 1359.29 Billion IDR | 21.2% |
| 2007 | 1121.53 Billion IDR | 3.79% |
| 2006 | 1080.56 Billion IDR | -40.69% |
| 2005 | 1822.02 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 4848.48 Billion IDR | 23.13% |
| 2024 Q3 | 4840.03 Billion IDR | -3.69% |
| 2024 Q2 | 5025.68 Billion IDR | 3.65% |
| 2023 Q2 | 5642.93 Billion IDR | 6.1% |
| 2023 Q3 | 4808.02 Billion IDR | -14.8% |
| 2023 Q1 | 5318.48 Billion IDR | 3.39% |
| 2023 Q4 | 3937.54 Billion IDR | -18.1% |
| 2023 FY | 3937.54 Billion IDR | -23.45% |
| 2022 Q4 | 5143.98 Billion IDR | 2.1% |
| 2022 Q3 | 5038.33 Billion IDR | 11.13% |
| 2022 Q2 | 4533.53 Billion IDR | -7.77% |
| 2022 Q1 | 4915.6 Billion IDR | 11.7% |
| 2022 FY | 5143.98 Billion IDR | 16.89% |
| 2021 Q1 | 4475.95 Billion IDR | 4.38% |
| 2021 Q4 | 4400.75 Billion IDR | 2.94% |
| 2021 Q3 | 4275.03 Billion IDR | 4.51% |
| 2021 Q2 | 4090.66 Billion IDR | -8.61% |
| 2021 FY | 4400.75 Billion IDR | 2.62% |
| 2020 Q4 | 4288.21 Billion IDR | -5.71% |
| 2020 FY | 4288.21 Billion IDR | 20.48% |
| 2020 Q1 | 4875.82 Billion IDR | 36.99% |
| 2020 Q2 | 4910.43 Billion IDR | 0.71% |
| 2020 Q3 | 4547.94 Billion IDR | -7.38% |
| 2019 Q3 | 3458.04 Billion IDR | -1.65% |
| 2019 Q4 | 3559.14 Billion IDR | 2.92% |
| 2019 FY | 3559.14 Billion IDR | 24.81% |
| 2019 Q1 | 3320.26 Billion IDR | 16.43% |
| 2019 Q2 | 3516.19 Billion IDR | 5.9% |
| 2018 Q4 | 2851.61 Billion IDR | -3.43% |
| 2018 Q3 | 2952.87 Billion IDR | -24.7% |
| 2018 FY | 2851.61 Billion IDR | 4.75% |
| 2018 Q1 | 2798.76 Billion IDR | 2.81% |
| 2018 Q2 | 3921.41 Billion IDR | 40.11% |
| 2017 Q1 | 2837.16 Billion IDR | 2.72% |
| 2017 FY | 2722.2 Billion IDR | -1.45% |
| 2017 Q4 | 2722.2 Billion IDR | -8.06% |
| 2017 Q3 | 2960.93 Billion IDR | -21.29% |
| 2017 Q2 | 3761.97 Billion IDR | 32.6% |
| 2016 FY | 2762.16 Billion IDR | 0.15% |
| 2016 Q4 | 2762.16 Billion IDR | -3.93% |
| 2016 Q2 | 2994.58 Billion IDR | 2.76% |
| 2016 Q3 | 2875.01 Billion IDR | -3.99% |
| 2016 Q1 | 2914.17 Billion IDR | 5.66% |
| 2015 Q3 | 2770.78 Billion IDR | 2.17% |
| 2015 Q1 | 2648.91 Billion IDR | 1.59% |
| 2015 FY | 2758.13 Billion IDR | 5.77% |
| 2015 Q4 | 2758.13 Billion IDR | -0.46% |
| 2015 Q2 | 2711.97 Billion IDR | 2.38% |
| 2014 FY | 2607.55 Billion IDR | -7.37% |
| 2014 Q4 | 2607.55 Billion IDR | -6.73% |
| 2014 Q3 | 2795.65 Billion IDR | -22.36% |
| 2014 Q1 | 2629.7 Billion IDR | -6.59% |
| 2014 Q2 | 3600.72 Billion IDR | 36.93% |
| 2013 FY | 2815.1 Billion IDR | 37.57% |
| 2013 Q2 | 3421.59 Billion IDR | 71.11% |
| 2013 Q1 | 1999.68 Billion IDR | -2.28% |
| 2013 Q4 | 2815.1 Billion IDR | 11.22% |
| 2013 Q3 | 2531 Billion IDR | -26.03% |
| 2012 Q3 | 1874.94 Billion IDR | -30.82% |
| 2012 Q4 | 2046.31 Billion IDR | 9.14% |
| 2012 Q2 | 2710.05 Billion IDR | 54.59% |
| 2012 Q1 | 1753.01 Billion IDR | -0.32% |
| 2012 FY | 2046.31 Billion IDR | 16.36% |
| 2011 FY | 1758.61 Billion IDR | 39.51% |
| 2011 Q4 | 1758.61 Billion IDR | 0.0% |
| 2010 FY | 1260.57 Billion IDR | -25.49% |
| 2009 FY | 1691.77 Billion IDR | 24.46% |
| 2008 FY | 1359.29 Billion IDR | 21.2% |
| 2007 FY | 1121.53 Billion IDR | 3.79% |
| 2006 FY | 1080.56 Billion IDR | -40.69% |
| 2005 FY | 1822.02 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|